Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Autoimmune Diseases × remdesivir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Respiratory Syncytial Virus Infections 1 Autoimmune Diseases 1

Interventions

fludarabine 3 Cyclophosphamide 3 Specimen Handling 2 remdesivir 1 Standard of Care 1 Practice Guidelines as Topic 1 Nivolumab 1 Music Therapy 1 Methods 1 Interviews as Topic 1 Educational Status 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06817889 2026-02-27

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Fred Hutchinson Cancer Center

Phase 2 Recruiting

Autoimmune Diseases, Respiratory Syncytial Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡